Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curtis Mathes is a small publicly traded U.S. company operating under the historic Curtis Mathes brand and focused primarily on solid-state lighting products rather than biotechnology or pharmaceuticals. Its disclosed business includes LED and other frequency-specific lighting solutions for consumer, industrial, horticultural, and phototherapy applications, with subsidiaries including Curtis Mathes Therapeutics and Curtis Mathes Grow Lights. The company has described therapeutic-lighting efforts centered on red-light and near-infrared applications for wound healing, inflammation reduction, and sports recovery, but it does not appear to operate as a conventional drug-development biotech company. For healthcare classification purposes, it is better characterized as a lighting/device business with adjacent wellness and phototherapy ambitions than as a life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curtis Mathes.